NewsDid Luxembourg Really Just Pay 3 Million Euros For...

Did Luxembourg Really Just Pay 3 Million Euros For 30 Kilos Of Medical Cannabis?

-

BEING the richest country in the world seems to have some inherent advantages. 

For Luxembourg has just spent €3m on 30 kilograms of medical cannabis – equating to the tidy sum of €100 per gram, reports Newsweed.

“The chosen offer is that of Canopy Growth Germany in collaboration with Tilray Germany. The products of the two suppliers come from Portugal and Canada,” said the Luxembourg Minister of Health Paulette Lenert in a written response addressed to a parliamentarian

Ms Lenert also specified that the Grand Duchy will receive 28.5 kilograms of cannabis flowers with a THC 18% / CBD ratio <1%, and 2.25 kilograms of herb balanced in THC / CBD.

This delivery is welcome in Luxembourg. The country has experienced a shortage of medical cannabis since March. The 700 or so patients treated with the flowers will soon be able to resume their treatment. This particularly concerns those who suffer from serious illnesses with chronic pain, cancer, or multiple sclerosis.

Equivalent To 100 Euros Per Gram

But this supply comes at a high price. 100 euros per gram is unheard of. “It must be a mistake, it’s not possible!, says Bertrand Rambaud, the representative of the Francophone Union for cannabinoids in medicine. 

Typically, wholesale purchase prices range from $2 to $3 per gram. Then on resale, it is around 7 euros. When I went to the Netherlands, the Bedrocan was sold at around €7.20 per gram. “

Luxembourgers also seem confused by this purchase price. In the commentary space of the newspaper L’Essentiel, many Internet users share their surprise: ‘100 euros per gram?! But it’s big nonsense’,’ Luxembourg is known to throw money down the drain’, ‘There must be an error, or then an intermediary who takes a good commission in the process’, were just some of the comments.

However, the government should not have too much trouble paying so much. Luxembourg is the richest country in the world, in terms of wealth per capita, according to the latest figures from the World Bank

But now, we will have to see how much Luxembourg medical cannabis will sell for. “If they buy it at 100 euros per gram, they will not sell it for 10 euros,” added Mr Rambaud.

1 COMMENT

  1. This is no help whatsoever to the people that actually need the medicine.

    Big companies still making huge amounts of profit, meanwhile people who are suffering cannot get hold of a natural medicine with no side effects that should be available to them cheaply and easily nearby. What a complete farce. This is very unfair on patients.

    I hope this is a mistake.

Comments are closed.

Latest news

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of a lull with little movement for European cannabis stocks. Last week’s...

Business of Cannabis Conference Returns to New York City on November 3rd

In this second summit, the most influential business leaders, investors and politicians gather to discuss social equity, policy and...

Curaleaf Takes Majority Stake And Forms Strategic Partnership With Germany’s Four 20 Pharma In €20m Deal

CURALEAF Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading U.S. provider of consumer products in cannabis, announced that Curaleaf International...

Columbia Care To ‘Wind Down’ Operations In UK & Europe

COLUMBIA Care has confirmed to BusinessCann that it is set to ‘wind down’ its operations across the UK and...

Akanda To Supply Cansativa With Premium Indoor Cannabis Flower Grown At Its Sintra Facility In Portugal

INTERNATIONAL medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has signed a...

Cannabis Companies With ESG Principles At Their Heart Are Now ‘The Ones That Are More Investable’

AS Tory leadership hopefuls continue their scramble to launch policies aimed at softening the blow of the looming cost-of-living...

Must read

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of...

Business of Cannabis Conference Returns to New York City on November 3rd

In this second summit, the most influential business leaders,...

You might also likeRELATED
Recommended to you